semaglutide device FDA Clears For Cardiac Risk Reduction in Diabetic Patients Novo Nordisk medicines containing semaglutide

Future treatments may increasingly integrate GLP-1 with other therapies for a holistic approach

Zheng S, Liu Y, Li P, Tian H

its about transforming your lifestyle and improving your overall health

Explore our wellness services or schedule a consultation to speak directly with a licensed clinician about what may be appropriate for you

Side Effects, Tolerability, and Safety Considerations Both medications share a common side effect profile rooted in slowed gastric movement: nausea, vomiting, constipation, and diarrhea occur most frequently during dose escalation and typically resolve within 12 weeks

Strength training, on the other hand, is essential for building the lean muscle that boosts your metabolism